FDA Approved: QINLOCK — Original Application (Deciphera Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Qinlock (ripretinib) by original application for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor after p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• QINLOCK (ripretinib)

Snippet

ORIG AP for QINLOCK (RIPRETINIB)